Market Overview:
The global Escherichia Coli (E. Coli) diagnostic testing market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of E. coli infections, technological advancements in diagnostics, and growing demand for point-of-care diagnostics. However, the high cost of advanced diagnostic tests may restrain the growth of this market during the forecast period. The global Escherichia Coli (E. Coli) diagnostic testing market can be segmented on the basis of type, application, and region. On the basis of type, the market can be divided into monoclonal antibodies, molecular diagnostics, differential light scattering techniques immunoassays flow cytometry chromatography and diagnostic imaging techniques . On the basis of application ,the Escherichia coli (E colI)diagnostic testingmarket can be classified into commercial or private labs hospitals public health labs academic research institutes .
 Diagnostic Testing Industry Outlook.svg)
Product Definition:
Escherichia coli (E. Coli) is a Gram-negative, rod-shaped bacterium that is commonly found in the lower intestine of warm-blooded animals. E. Coli can cause a wide range of diseases in humans, ranging from relatively mild intestinal illness to life-threatening systemic infections. E. Coli diagnostic testing is used to identify and isolate E. coli strains from clinical specimens, including blood, stool, and urine samples. The results of this testing can help guide the selection of appropriate antimicrobial therapy for patients with suspected E.
Monoclonal Antibodies:
Monoclonal antibodies are antibody molecules that are manufactured by the body's immune system to fight off infections and diseases. The most common types of monoclonal antibodies include immunoglobulin G (IgG), immunoglobulin M (IgM), and Immunoglobin E (IgE). These antibodies can be used in a wide range of applications including diagnosis, drug development & manufacturing, therapeutic protein engineering for treatment of various diseases such as cancer.
Molecular Diagnostics:
Molecular diagnostics is a set of procedures used to identify and analyze genetic elements (DNA, RNA) in a molecule. It is the most precise method available today for accurate disease diagnosis. The process also helps determine the cause of diseases by providing information about the location and nature of any changes that have taken place in the genetic material.
Application Insights:
The market is segmented into commercial or private labs, hospitals, public health laboratories, and academic research institutes. The hospitals segment dominated the global market in 2017 owing to the rising prevalence of chronic diseases such as cancer and diabetes. In addition, a rise in the number of hospital-acquired E. coli infections is expected to drive demand for diagnostic tests over the forecast period.
The public health laboratories are anticipated to witness lucrative growth during the forecast period due to an increase in government funding for disease control programs across various regions including North America and Europe. Furthermore, an increase in investment by companies such as Thermo Fisher Scientific Inc.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high adoption rate for new technologies, and availability of advanced products. The region is expected to maintain its dominance throughout the forecast period owing to continuous technological advancements and increasing demand for E coli testing kits from both commercial as well as private sectors.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to factors such as rising disposable income, improving healthcare infrastructure & expenditure along with growing awareness about early diagnosis among people in countries like China & India which are leading contributors towards this region’s growth such as Japan and Australia respectively.
Growth Factors:
- Increasing incidence of E. Coli infections: The incidence of E. Coli infections is increasing globally due to the changing lifestyle and food habits, growing population, and increasing travel activities. This is expected to drive the demand for E. Coli diagnostic testing over the next few years.
- Growing awareness about E. Coli infections: There is a growing awareness among people about the symptoms and treatment of E. Coli infections across the globe, which is expected to boost demand for diagnostic tests for this pathogen in the coming years
Scope Of The Report
Report Attributes
Report Details
Report Title
Escherichia Coli (E. Coli) Diagnostic Testing Market Research Report
By Type
Monoclonal Antibodies, Molecular Diagnostics, Differential Light Scattering, Immunoassays, Flow Cytometry, Chromatography, Diagnostic Imaging
By Application
Commercial or Private Labs, Hospitals, Public Health Labs, Academic Research Institutes
By Companies
Abbott Laboratories, Beckman Coulter, Wako, Becton, Dickinson and Company, Affymetrix, bioMérieux, Bio-Rad Laboratories, Thermo Fisher Scientific, Siemens, Hoffmann-La Roche, Cepheid, GenBio, Olympus, Novartis, Johnson & Johnson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
153
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Escherichia Coli (E. Coli) Diagnostic Testing Market Report Segments:
The global Escherichia Coli (E. Coli) Diagnostic Testing market is segmented on the basis of:
Types
Monoclonal Antibodies, Molecular Diagnostics, Differential Light Scattering, Immunoassays, Flow Cytometry, Chromatography, Diagnostic Imaging
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Commercial or Private Labs, Hospitals, Public Health Labs, Academic Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Beckman Coulter
- Wako
- Becton
- Dickinson and Company
- Affymetrix
- bioMérieux
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Siemens
- Hoffmann-La Roche
- Cepheid
- GenBio
- Olympus
- Novartis
- Johnson & Johnson
 Diagnostic Testing Market Overview.svg)
Highlights of The Escherichia Coli (E. Coli) Diagnostic Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monoclonal Antibodies
- Molecular Diagnostics
- Differential Light Scattering
- Immunoassays
- Flow Cytometry
- Chromatography
- Diagnostic Imaging
- By Application:
- Commercial or Private Labs
- Hospitals
- Public Health Labs
- Academic Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Escherichia Coli (E. Coli) Diagnostic Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Diagnostic Testing Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Escherichia coli (E. Coli) diagnostic testing is used to determine the presence or absence of E. Coli in a sample. This type of testing can be used to help diagnose various types of infections, including gastrointestinal problems, urinary tract infections, and pneumonia.
Some of the major companies in the escherichia coli (e. coli) diagnostic testing market are Abbott Laboratories, Beckman Coulter, Wako, Becton, Dickinson and Company, Affymetrix, bioM©rieux, Bio-Rad Laboratories, Thermo Fisher Scientific, Siemens, Hoffmann-La Roche, Cepheid, GenBio, Olympus, Novartis, Johnson & Johnson.
The escherichia coli (e. coli) diagnostic testing market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Escherichia Coli (E. Coli) Diagnostic Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Escherichia Coli (E. Coli) Diagnostic Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Escherichia Coli (E. Coli) Diagnostic Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Escherichia Coli (E. Coli) Diagnostic Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Size & Forecast, 2018-2028
4.5.1 Escherichia Coli (E. Coli) Diagnostic Testing Market Size and Y-o-Y Growth
4.5.2 Escherichia Coli (E. Coli) Diagnostic Testing Market Absolute $ Opportunity
Chapter 5 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Type
5.2.1 Monoclonal Antibodies
5.2.2 Molecular Diagnostics
5.2.3 Differential Light Scattering
5.2.4 Immunoassays
5.2.5 Flow Cytometry
5.2.6 Chromatography
5.2.7 Diagnostic Imaging
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Applications
6.2.1 Commercial or Private Labs
6.2.2 Hospitals
6.2.3 Public Health Labs
6.2.4 Academic Research Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Escherichia Coli (E. Coli) Diagnostic Testing Analysis and Forecast
9.1 Introduction
9.2 North America Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Type
9.6.1 Monoclonal Antibodies
9.6.2 Molecular Diagnostics
9.6.3 Differential Light Scattering
9.6.4 Immunoassays
9.6.5 Flow Cytometry
9.6.6 Chromatography
9.6.7 Diagnostic Imaging
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Applications
9.10.1 Commercial or Private Labs
9.10.2 Hospitals
9.10.3 Public Health Labs
9.10.4 Academic Research Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Escherichia Coli (E. Coli) Diagnostic Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Type
10.6.1 Monoclonal Antibodies
10.6.2 Molecular Diagnostics
10.6.3 Differential Light Scattering
10.6.4 Immunoassays
10.6.5 Flow Cytometry
10.6.6 Chromatography
10.6.7 Diagnostic Imaging
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Applications
10.10.1 Commercial or Private Labs
10.10.2 Hospitals
10.10.3 Public Health Labs
10.10.4 Academic Research Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Escherichia Coli (E. Coli) Diagnostic Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Type
11.6.1 Monoclonal Antibodies
11.6.2 Molecular Diagnostics
11.6.3 Differential Light Scattering
11.6.4 Immunoassays
11.6.5 Flow Cytometry
11.6.6 Chromatography
11.6.7 Diagnostic Imaging
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Applications
11.10.1 Commercial or Private Labs
11.10.2 Hospitals
11.10.3 Public Health Labs
11.10.4 Academic Research Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Escherichia Coli (E. Coli) Diagnostic Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Type
12.6.1 Monoclonal Antibodies
12.6.2 Molecular Diagnostics
12.6.3 Differential Light Scattering
12.6.4 Immunoassays
12.6.5 Flow Cytometry
12.6.6 Chromatography
12.6.7 Diagnostic Imaging
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Applications
12.10.1 Commercial or Private Labs
12.10.2 Hospitals
12.10.3 Public Health Labs
12.10.4 Academic Research Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Escherichia Coli (E. Coli) Diagnostic Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Type
13.6.1 Monoclonal Antibodies
13.6.2 Molecular Diagnostics
13.6.3 Differential Light Scattering
13.6.4 Immunoassays
13.6.5 Flow Cytometry
13.6.6 Chromatography
13.6.7 Diagnostic Imaging
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast by Applications
13.10.1 Commercial or Private Labs
13.10.2 Hospitals
13.10.3 Public Health Labs
13.10.4 Academic Research Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Escherichia Coli (E. Coli) Diagnostic Testing Market: Competitive Dashboard
14.2 Global Escherichia Coli (E. Coli) Diagnostic Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Beckman Coulter
14.3.3 Wako
14.3.4 Becton
14.3.5 Dickinson and Company
14.3.6 Affymetrix
14.3.7 bioMérieux
14.3.8 Bio-Rad Laboratories
14.3.9 Thermo Fisher Scientific
14.3.10 Siemens
14.3.11 Hoffmann-La Roche
14.3.12 Cepheid
14.3.13 GenBio
14.3.14 Olympus
14.3.15 Novartis
14.3.16 Johnson & Johnson
